Navigation Links
Frost & Sullivan Honours LyondellBasell With Customer Value Enhancement Award
Date:4/7/2009

LONDON, April 7 /PRNewswire/ -- The 2008 Frost & Sullivan Global Plastics in Medical Devices Customer Value Enhancement Award is presented to LyondellBasell Industries. The award recognises LyondellBasell's status as a one-stop-shop for its customers in the global medical devices market.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

"LyondellBasell differentiates itself from many of its competitors by offering customised products and services catering to the global healthcare market," states Frost & Sullivan Research Analyst Hariharan Ramasubramanian. "By adopting such a focused approach to medical devices, LyondellBasell is optimally positioned to create and enhance value for its customers."

LyondellBasell has historically been at the forefront in promoting the use of polyolefins in the medical device industry with its highly popular Purell brand. LyondellBasell offers strong technical support to its customers, while providing them with product certificates necessary for use of its Purell products in medical devices.

"LyondellBasell's Medical Protocol provides its clients with a certified product that complies with the requirements of European and US pharmacopoeia," notes Ramasubramanian. "This enables customers to rapidly get approvals for use of these materials in their medical devices and streamlines the complex validation process governing the use of OEM products in the medical sector."

Moreover, any changes that might be required to the raw material are notified to clients in principle at least 24 months in advance. This is a critical facility that cannot be provided by raw material suppliers that sell standard grades of polyolefins to the market.

The merger of Lyondell and Basell in 2007 has further boosted LyondellBasell's value proposition. This strategic approach has enabled LyondellBasell to provide more regional support to its clients, service markets from local production capabilities as far as possible and leverage on its strong regulatory understanding of the medical device markets to help clients in various regions.

"This combination further solidifies LyondellBasell's position as a one-stop-shop for its customers," says Ramasubramanian. "This is not only in terms of its immense product range, technical and regulatory services, but also because of its ability to provide these on a global basis."

A customer centric approach to the medical device industry also makes it possible for LyondellBasell to identify unmet needs in the industry better than the competition, and to be highly responsive to these requirements through its immense strengths in R&D.

For instance, realising the need and new regulatory requirements for a film polyolefin product line, LyondellBasell introduced new grades of low density polyethylene to this market in 2007, completing its offerings to the injection and blow moulded polyolefins market.

The Customer Value Enhancement Award is presented to the company that has best demonstrated the ability to expand its customer base, while maintaining its existing customer base, with more innovative value creation and enhancement strategies than competing vendors. This Award recognises the company's successful sales entry, customer acquisition and service strategies, and the degree to which those strategies have met customers' stated needs and requirements. Such strategies are expected to significantly improve customer interaction and contribute to customer satisfaction.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About LyondellBasell

LyondellBasell Industries is one of the world's largest polymers, petrochemicals and fuels companies. It is the global leader in polyolefins technology, production and marketing; a pioneer in propylene oxide and derivatives; and a significant producer of fuels and refined products, including biofuels. Through research and development, LyondellBasell develops innovative materials and technologies that deliver exceptional customer value and products that improve quality of life for people around the world. Headquartered in The Netherlands, LyondellBasell (www.lyondellbasell.com) is privately owned by Access Industries.

    Contact:
    Dr. Michael Luetke, Global Marketing Manager, Healthcare Applications
    Tel: +49 69 30 51 57 24 or
    michael.luetke@lyondellbasell.com

    Media contact - Waldemar Oldenburger, +49 69 305 854 59 or
    waldemar.oldenburger@lyondellbasell.com

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

    Contact:
    Catherine Brassell
    Promotions Coordinator - EMEA
    Best Practices
    catherine.brassell@frost.com
    P: +44.207.915.7867
   http://www.frost.com/


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Rise in Sleeping Disorders Triggers High Demand for Sleep Service Facilities in Europe, Notes Frost & Sullivan
2. BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivans Product Innovation of the Year Award
3. Kenyan Pharmaceutical Industry Can Expect Significant Growth Despite Global Conditions, Finds Frost & Sullivan
4. Tough Recessionary Times, but Frost & Sullivan Believes Its Not All Gloomy for African Healthcare Markets
5. Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia
6. Frost & Sullivan: End-to-End Integration of HD Devices in the Operating Room Ushers in a New Era in Disruptive Technology
7. Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan
8. Frost & Sullivan Accolade for Ferring Pharmaceuticals
9. Leveraging the Third Amendment Ruling the Risk Management Process: Frost & Sullivans Assessment of Regulations for Medical Imaging Equipment in Europe
10. Frost & Sullivan Honours Outstanding Achievements in Healthcare
11. Sentinelle Medical Receives Frost & Sullivan Excellence in Technology Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Healthcare Associates of ... Center at Craig Ranch building at 8080 State Highway 121, Suite 210, McKinney, Texas ... easy access to Highway 121. , As the practice has grown, the need for ...
(Date:2/24/2017)... , ... February 24, 2017 , ... The International Association ... annual “Imagine Me Beyond What You See” body image mannequin art competition. Selected from ... be showcased and the winner revealed at the 31st annual iaedp Symposium, March 22 ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... again hosted their Military Wedding Giveaway, with the winning couple announced on Feb. ... with services generously donated from local vendors: A Matter of Taste, Ryan Rousseau ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... outlet with a clinician-based audience, will be participating in Rare Disease Day events, ... Washington, D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly ...
(Date:2/23/2017)... IPSWICH, Mass. (PRWEB) , ... February 23, 2017 ... ... chosen as an approved content provider for the National Institute for Health ... care and social care-related organizations in the National Health Service (NHS) to search, ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an ... that it has acquired exclusive worldwide rights to ... innovative HDAC inhibitor targeting hematological and solid tumors. ... Phase 1 and 2 clinical trials of Abexinostat ... have already been completed, demonstrating that Abexinostat ...
(Date:2/23/2017)... Feb. 23, 2017  Genesis Healthcare Services has merged ... was made by Bill Monast , President and ... and Nathan Feltman , executives with Home Health ... LLC. This acquisition helps Hospice Cloud ... technology enabled durable medical equipment (DME) solutions for the ...
(Date:2/23/2017)... REDWOOD CITY, Calif., Feb. 23, 2017 Nevro Corp. ... innovative evidence-based solutions for the treatment of chronic pain, today ... ended December 31, 2016. 2016 Accomplishment & ... the full year 2016, an increase of 228% as reported, ... million for 2016, an increase of 612% over the prior ...
Breaking Medicine Technology: